↓ Skip to main content

Impact of Oncotype DX testing on ER+ breast cancer treatment and survival in the first decade of use

Overview of attention for article published in Breast Cancer Research, July 2021
Altmetric Badge

Mentioned by

twitter
2 X users

Citations

dimensions_citation
30 Dimensions

Readers on

mendeley
58 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Impact of Oncotype DX testing on ER+ breast cancer treatment and survival in the first decade of use
Published in
Breast Cancer Research, July 2021
DOI 10.1186/s13058-021-01453-4
Pubmed ID
Authors

Evelien Schaafsma, Baoyi Zhang, Merit Schaafsma, Chun-Yip Tong, Lanjing Zhang, Chao Cheng

X Demographics

X Demographics

The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 58 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 58 100%

Demographic breakdown

Readers by professional status Count As %
Student > Master 7 12%
Other 6 10%
Student > Bachelor 3 5%
Student > Postgraduate 3 5%
Researcher 3 5%
Other 8 14%
Unknown 28 48%
Readers by discipline Count As %
Biochemistry, Genetics and Molecular Biology 11 19%
Medicine and Dentistry 8 14%
Unspecified 2 3%
Nursing and Health Professions 2 3%
Agricultural and Biological Sciences 1 2%
Other 3 5%
Unknown 31 53%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 17 July 2023.
All research outputs
#20,356,726
of 25,837,817 outputs
Outputs from Breast Cancer Research
#1,694
of 2,078 outputs
Outputs of similar age
#308,912
of 432,612 outputs
Outputs of similar age from Breast Cancer Research
#21
of 26 outputs
Altmetric has tracked 25,837,817 research outputs across all sources so far. This one is in the 18th percentile – i.e., 18% of other outputs scored the same or lower than it.
So far Altmetric has tracked 2,078 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 12.3. This one is in the 16th percentile – i.e., 16% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 432,612 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 24th percentile – i.e., 24% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 26 others from the same source and published within six weeks on either side of this one. This one is in the 19th percentile – i.e., 19% of its contemporaries scored the same or lower than it.